Search

everythinglearnresearchcommunity

for

Search:↓

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

The patient has frontal fibrosing alopecia (FFA).

Alternating treatment with two drugs could help cells in a rapid aging disease.

The fer-ts mutation in plants prevents root hair growth at high temperatures.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Nelfb is essential for dermal fat development and survival.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.